|Articles|May 12, 2023
Pharma 2023: Vaccines Journey to the Consumer
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Advertisement
At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
3
FDA Pauses Release of New CRL’s Following Citizen’s Petition
4
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
5